Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter Topoisomerase II alpha Antikörper (AA 1352-1493)

Dieser Maus Monoklonal Antikörper detektiert spezifisch Topoisomerase II alpha in IHC. Es zeigt Reaktivität gegenüber Proben von Human und Maus.
Produktnummer ABIN7127010
639,45 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 6 bis 10 Werktagen

Kurzübersicht für Rekombinanter Topoisomerase II alpha Antikörper (AA 1352-1493) (ABIN7127010)

Target

Alle Topoisomerase II alpha (TOP2A) Antikörper anzeigen
Topoisomerase II alpha (TOP2A) (Topoisomerase (DNA) II alpha 170kDa (TOP2A))

Antikörpertyp

Recombinant Antibody

Reaktivität

  • 193
  • 85
  • 46
  • 9
  • 6
  • 3
  • 3
  • 3
  • 1
Human, Maus

Wirt

  • 143
  • 51
Maus

Klonalität

  • 100
  • 94
Monoklonal

Konjugat

  • 121
  • 10
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser Topoisomerase II alpha Antikörper ist unkonjugiert

Applikation

  • 135
  • 92
  • 52
  • 52
  • 40
  • 23
  • 18
  • 9
  • 1
  • 1
  • 1
  • 1
Immunohistochemistry (IHC)

Klon

RTOP2A-6629
  • Bindungsspezifität

    • 29
    • 15
    • 14
    • 11
    • 10
    • 9
    • 8
    • 7
    • 6
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1352-1493

    Verwendungszweck

    Recombinant Topoisomerase II alpha (Proliferation & Drug-Resistance Marker) Antibody

    Spezifität

    It recognizes a 170kDa protein, which is identified as topoisomerase II°™. It shows no cross-reaction with Topoisomerase II æ or I. Topo II °™ plays important roles in synthesis and transcription of DNA as well as chromosomal segregation during mitosis. It is reported to be a sensitive and specific marker of late S-, G2- & M-phases in transformed and developmentally regulated normal cells. Topo II °™ is also implicated in drug resistance of tumor cells and has been shown to be over-expressed in many human cancers. Decreased expression of Topo IIa is the predominant mechanism of resistance to several chemotherapeutic agents.

    Kreuzreaktivität (Details)

    Human and Mouse.

    Aufreinigung

    200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.

    Immunogen

    Recombinant human Topoisomerase II alpha fragment (aa1352-1493)

    Isotyp

    IgG1, kappa
  • Applikationshinweise

    Known_Application: Immunohistochemistry (Formalin-fixed) (0.5-1 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95 °C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Positive_Control: Human lymph node or tonsil.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1.0 mg/mL

    Buffer

    Prepared in 10  mM PBS

    Konservierungsmittel

    Azide free

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Antibody with azide - store at 2 to 8 °C. Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Haltbarkeit

    24 months
  • Target

    Topoisomerase II alpha (TOP2A) (Topoisomerase (DNA) II alpha 170kDa (TOP2A))

    Andere Bezeichnung

    TOP2A

    Hintergrund

    ATP hydrolyzing DNA topoisomerase II alfa, DNA gyrase, DNA topoisomerase (ATP hydrolyzing), DNA topoisomerase 2 alpha, DNA topoisomerase II 170kD, DNA topoisomerase II alpha, DNA Topoisomerase2, TOP2A, Topoisomerase DNA II alpha 170 kDa, TP2A

    Human lymph node or tonsil.

    Molekulargewicht

    170kDa

    Gen-ID

    7153, 156346

    UniProt

    P11388

    Pathways

    Zellzyklus, Mitotic G1-G1/S Phases
Sie sind hier:
Chat with us!